Profile data is unavailable for this security.
About the company
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.
- Revenue in USD (TTM)2.52bn
- Net income in USD246.20m
- Incorporated2000
- Employees3.90k
- LocationInsulet Corp100 Nagog ParkACTON 01720-3440United StatesUSA
- Phone+1 (978) 600-7000
- Fax+1 (978) 600-0120
- Websitehttps://www.omnipod.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter International Inc | 11.02bn | -355.00m | 11.17bn | 38.00k | -- | 1.54 | 17.65 | 1.01 | -0.6925 | -0.6654 | 21.46 | 14.09 | 0.4618 | 3.14 | 6.08 | 290,078.90 | -1.48 | -0.8441 | -1.87 | -1.03 | 35.05 | 38.63 | -3.20 | -2.03 | 1.18 | 3.42 | 0.5684 | -- | 2.66 | -1.31 | -293.68 | -- | -8.52 | 1.60 |
| Revvity Inc | 2.86bn | 239.88m | 11.52bn | 11.00k | 49.05 | 1.59 | 17.85 | 4.03 | 2.07 | 2.08 | 24.49 | 63.95 | 0.2326 | 3.46 | 4.15 | -- | 1.95 | 3.23 | 2.13 | 3.58 | 54.77 | 58.48 | 8.40 | 13.58 | 1.40 | 5.23 | 0.3075 | 8.52 | 3.67 | -5.47 | -15.26 | -19.91 | -1.05 | 0.00 |
| Globus Medical Inc | 2.77bn | 423.78m | 11.75bn | 5.30k | 28.38 | 2.69 | 16.79 | 4.24 | 3.09 | 3.09 | 20.09 | 32.68 | 0.5441 | 1.29 | 4.59 | 522,604.50 | 8.32 | 4.70 | 9.53 | 5.18 | 65.34 | 66.40 | 15.30 | 9.73 | 2.47 | 15.96 | 0.0002 | 0.00 | 60.62 | 26.25 | -16.19 | -7.88 | 10.29 | -- |
| Guardant Health Inc | 902.57m | -398.79m | 13.12bn | 2.00k | -- | -- | -- | 14.54 | -3.21 | -3.21 | 7.27 | -2.84 | 0.6411 | 4.02 | 8.85 | 451,510.30 | -28.33 | -24.20 | -33.49 | -26.83 | 63.76 | 63.23 | -44.18 | -91.24 | 3.12 | -10.70 | 1.47 | -- | 31.04 | 28.08 | 8.98 | -- | 10.58 | -- |
| Penumbra Inc | 1.33bn | 164.03m | 13.38bn | 4.50k | 82.29 | 9.83 | 73.74 | 10.03 | 4.14 | 4.14 | 33.63 | 34.70 | 0.8276 | 1.07 | 7.42 | 296,399.60 | 10.18 | 1.42 | 11.31 | 1.58 | 66.80 | 63.21 | 12.30 | 1.96 | 4.18 | -- | 0.0171 | 0.00 | 12.86 | 16.89 | -84.59 | -21.98 | -0.853 | -- |
| Align Technology Inc | 4.03bn | 410.35m | 13.46bn | 20.95k | 33.15 | 3.32 | 32.83 | 3.34 | 5.66 | 5.66 | 55.58 | 56.43 | 0.6483 | 5.33 | 3.85 | -- | 6.59 | 8.11 | 9.67 | 11.97 | 68.25 | 70.40 | 10.17 | 12.31 | 1.24 | -- | -- | -- | 0.899 | 10.30 | -2.61 | -25.40 | -- | -- |
| Solventum Corp | 8.40bn | 1.52bn | 13.55bn | 22.00k | 8.99 | 2.72 | 6.63 | 1.61 | 8.69 | 8.69 | 48.01 | 28.75 | 0.5851 | 3.85 | 7.91 | 381,909.10 | 10.61 | -- | 13.32 | -- | 54.18 | -- | 18.13 | -- | 1.14 | 1.76 | 0.5075 | -- | 0.6954 | -- | -64.41 | -- | -- | -- |
| Cooper Companies Inc | 4.09bn | 374.90m | 16.09bn | 15.00k | 43.82 | 1.95 | 21.39 | 3.93 | 1.87 | 1.87 | 20.46 | 42.06 | 0.3312 | 1.71 | 5.29 | 272,826.70 | 3.03 | 8.04 | 3.32 | 8.86 | 65.54 | 66.01 | 9.16 | 24.66 | 1.13 | 6.32 | 0.2332 | 0.2049 | 5.06 | 10.98 | -4.44 | 9.48 | 3.15 | -- |
| Hologic Inc | 4.13bn | 543.80m | 16.70bn | 7.07k | 31.05 | 3.18 | 19.90 | 4.05 | 2.41 | 2.41 | 18.28 | 23.51 | 0.4608 | 2.57 | 6.79 | 583,663.40 | 6.07 | 11.22 | 6.82 | 12.85 | 56.51 | 60.20 | 13.18 | 21.99 | 3.32 | 15.76 | 0.3246 | 0.00 | 1.74 | 1.66 | -28.35 | -12.69 | -0.5168 | -- |
| Insulet Corp | 2.52bn | 246.20m | 17.02bn | 3.90k | 70.19 | 12.30 | 51.00 | 6.75 | 3.45 | 3.45 | 34.85 | 19.68 | 0.833 | 1.62 | 6.02 | 646,641.00 | 8.13 | 6.00 | 10.05 | 7.03 | 71.46 | 67.05 | 9.76 | 9.22 | 2.18 | 27.39 | 0.423 | 0.00 | 22.07 | 22.92 | 102.76 | 104.84 | -4.75 | -- |
| Zimmer Biomet Holdings Inc | 8.01bn | 805.20m | 17.82bn | 17.00k | 22.25 | 1.40 | 9.47 | 2.22 | 4.04 | 4.04 | 40.22 | 64.36 | 0.3544 | 0.943 | 5.20 | 471,235.30 | 3.57 | 2.34 | 4.12 | 2.68 | 71.44 | 71.18 | 10.08 | 7.60 | 1.39 | 5.41 | 0.3886 | 37.52 | 3.85 | -0.7725 | -11.74 | 2.05 | -3.69 | 0.00 |
| West Pharmaceutical Services Inc | 3.02bn | 491.70m | 17.91bn | 10.60k | 36.89 | 5.87 | 27.80 | 5.93 | 6.75 | 6.75 | 41.41 | 42.44 | 0.7757 | 4.63 | 5.13 | 284,707.60 | 12.32 | 15.61 | 14.46 | 18.70 | 35.58 | 38.00 | 15.88 | 18.84 | 2.18 | -- | 0.0638 | 10.20 | -1.92 | 9.48 | -16.97 | 15.31 | 24.43 | 5.84 |
| Illumina Inc | 4.34bn | 850.00m | 18.29bn | 8.97k | 21.91 | 6.72 | 25.41 | 4.21 | 5.46 | 5.46 | 27.84 | 17.82 | 0.6709 | 2.61 | 5.41 | -- | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | -- | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -- | -- |
| Waters Corp | 3.11bn | 648.81m | 22.70bn | 7.60k | 35.09 | 9.74 | 26.66 | 7.31 | 10.87 | 10.87 | 52.02 | 39.15 | 0.6626 | 2.33 | 4.38 | 408,636.60 | 13.84 | 18.41 | 17.76 | 23.46 | 58.96 | 58.71 | 20.89 | 22.81 | 1.08 | 14.57 | 0.3765 | 0.00 | 0.0667 | 4.22 | -0.6851 | 1.61 | -2.75 | -- |
Data as of Feb 06 2026. Currency figures normalised to Insulet Corp's reporting currency: US Dollar USD
49.49%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 8.00m | 11.36% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2025 | 6.80m | 9.66% |
| Capital Research & Management Co. (Global Investors)as of 30 Sep 2025 | 4.55m | 6.46% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 4.43m | 6.29% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 3.09m | 4.39% |
| Baillie Gifford & Co.as of 31 Dec 2025 | 2.05m | 2.91% |
| Geode Capital Management LLCas of 30 Sep 2025 | 1.97m | 2.79% |
| ClearBridge Investments LLCas of 30 Sep 2025 | 1.47m | 2.08% |
| American Century Investment Management, Inc.as of 30 Sep 2025 | 1.41m | 2.00% |
| FIL Investments Internationalas of 30 Sep 2025 | 1.09m | 1.55% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
